Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Singapore Health Services Pte. Ltd. has 7 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 7 examiners and 6 art units, so examination is broadly distributed, with one art unit receiving more than one assignment. Counsel should use centralized tracking while preserving application-specific analysis.
BEE, ANDREW W. is the busiest examiner, with 1 pending matter. The profile shows no meaningful concentration with one examiner, making consistent scientific support and terminology important across the separate examination relationships.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (29%) |
| §112 only | 1 (14%) |
| Multi-statute (no §101) | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEE, ANDREW W. | 1 | 73.0% | +32.2% |
| HOLT, ANDRIAE M | 1 | 49.5% | +23.0% |
| EDGINGTONGIORDANO, FRANCESCA | 1 | 71.8% | +29.4% |
| LEBRON DE JESUS, GRACIELA NATALIA | 1 | 31.3% | +70.9% |
| MOLOYE, TITILAYO | 1 | 62.3% | +48.3% |
| KAPUSHOC, STEPHEN THOMAS | 1 | 46.5% | +53.8% |
| MARRISON, SAMUEL JOSEPH | 1 | 68.6% | +35.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17796293 | Biomarkers for Risk Prediction of Parkinson's Disease | KAPUSHOC, STEPHEN THOMAS | 27d |
| 18665536 | SYSTEM AND METHOD FOR SEGMENTING MEDICAL IMAGES | BEE, ANDREW W. | — |
| 18580830 | AN ANTI-ANGIOGENIC AGENT AND RELATED METHODS | HOLT, ANDRIAE M | — |
| 18290242 | CHIMERIC ANTIGEN RECEPTORS AND MODIFIED CELLS COMPRISING THE SAME | EDGINGTONGIORDANO, FRANCESCA | — |
| 18551573 | A CONNECTOR FOR A FLUIDIC CIRCUIT | LEBRON DE JESUS, GRACIELA NATALIA | — |
| 18006136 | A METHOD OF GENERATING AN INDUCED PLURIPOTENT STEM CELL, AN INDUCED PLURIPOTENT STEM CELL AND METHODS OF USING THE INDUCED PLURIPOTENT STEM CELL | MOLOYE, TITILAYO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17796293 | Biomarkers for Risk Prediction of Parkinson's Disease | KAPUSHOC, STEPHEN THOMAS | 27d |
| 17288863 | DEVICE AND METHOD FOR OPTHALMIC EXTRACTION AND INJECTION | MARRISON, SAMUEL JOSEPH | 56d |
| 18665536 | SYSTEM AND METHOD FOR SEGMENTING MEDICAL IMAGES | BEE, ANDREW W. | — |
| 18580830 | AN ANTI-ANGIOGENIC AGENT AND RELATED METHODS | HOLT, ANDRIAE M | — |
| 18290242 | CHIMERIC ANTIGEN RECEPTORS AND MODIFIED CELLS COMPRISING THE SAME | EDGINGTONGIORDANO, FRANCESCA | — |
| 18551573 | A CONNECTOR FOR A FLUIDIC CIRCUIT | LEBRON DE JESUS, GRACIELA NATALIA | — |
| 18006136 | A METHOD OF GENERATING AN INDUCED PLURIPOTENT STEM CELL, AN INDUCED PLURIPOTENT STEM CELL AND METHODS OF USING THE INDUCED PLURIPOTENT STEM CELL | MOLOYE, TITILAYO | — |
| Art Unit | Apps |
|---|---|
| 2669 | 1 |
| 1643 | 1 |
| 3785 | 1 |
| 1632 | 1 |
| 1683 | 1 |
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18665536 | SYSTEM AND METHOD FOR SEGMENTING MEDICAL IMAGES | BEE, ANDREW W. | 2669 | §101§102§103 | Non-Final OA | — | Pending | May 15, 2024 |
| 18580830 | AN ANTI-ANGIOGENIC AGENT AND RELATED METHODS | HOLT, ANDRIAE M | — | §102§103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18290242 | CHIMERIC ANTIGEN RECEPTORS AND MODIFIED CELLS COMPRISING THE SAME | EDGINGTONGIORDANO, FRANCESCA | 1643 | §102§103 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18551573 | A CONNECTOR FOR A FLUIDIC CIRCUIT | LEBRON DE JESUS, GRACIELA NATALIA | 3785 | §102§103 | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18006136 | A METHOD OF GENERATING AN INDUCED PLURIPOTENT STEM CELL, AN INDUCED PLURIPOTENT STEM CELL AND METHODS OF USING THE INDUCED PLURIPOTENT STEM CELL | MOLOYE, TITILAYO | 1632 | §103§112 | Non-Final OA | — | Pending | Jan 19, 2023 |
| 17796293 | Biomarkers for Risk Prediction of Parkinson's Disease | KAPUSHOC, STEPHEN THOMAS | 1683 | §101§112 | Final Rejection | 27d | Pending | Jul 29, 2022 |
| 17288863 | DEVICE AND METHOD FOR OPTHALMIC EXTRACTION AND INJECTION | MARRISON, SAMUEL JOSEPH | 3783 | §112 | Final Rejection | 56d | Pending | Apr 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSingapore Health Services Pte. Ltd. has 7 pending office actions as of October 2026, spread across 6 art units and 7 examiners.
Andrew W. Bee has the most, with 1 of Singapore Health Services Pte. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
